Haemoctin® becomes the company’s first biological product in the plasma-derived segment, offering a cost-effective alternative for the treatment of hemophilia in the region. This partnership reinforces SteinCares’ leadership in expanding access to...
SteinCares has strengthened its product portfolio in Colombia through an expanded agreement with Pharmacosmos for the commercialization and distribution of Monofer®, an innovative intravenous iron replacement therapy. This alliance reinforces SteinCares’...
SteinCares assumes Sandoz’s portfolio in Colombia, strengthening its leading position in the Latin American specialty healthcare market. The agreement positions SteinCares to achieve over $50 million in sales in Colombia by 2024, establishing the country as the...
Strategic partnership in Latin America extended to cover five additional products in therapeutic categories including oncology, pulmonary hypertension, and rare diseases. The current market size of the products included in the agreement exceeds USD 100 million. Adalvo...
IFC’s direct equity investment will accelerate SteinCares’ geographical growth and strengthen its portfolio of innovative and biosimilar medicines. San Jose, Costa Rica, May 29, 2023—The International Finance Corporation (IFC), a member of the World Bank Group,...